FentaNYL 100 mcg/ Injection for IV or IM Use recalled over sterility concerns
- Recall date
- December 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals recalls fentaNYL 100 mcg/2mL Injection for IV or IM Use, 2 mL Single Dose Syringe, CII, Rx Only, SCA Pharmaceuticals, 755 Rainb…
- Recall number
- D-0214-2021
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Product was distributed to hospitals nationwide.
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
fentaNYL 100 mcg/2mL Injection for IV or IM Use, 2 mL Single Dose Syringe, CII, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095 barcode 70004020006
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals